Recruiting studies: Digestive System Neuroendocrine Tumor G1

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Natural History of Familial Carcinoid Tumor
Phase N/A · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT00646022 Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroe
Phase 2 · 39 location(s) · National Cancer Institute (NCI) · NCT05773274 Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
NA · 1 location(s) · Cedars-Sinai Medical Center · NCT04907643 Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroend
Phase 4 · 1 location(s) · Vanderbilt-Ingram Cancer Center · NCT06016855 EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers
Phase 1/Phase 2 · 14 location(s) · Shanghai EpimAb Biotherapeutics Co., Ltd. · NCT05176665 Combination External Radiation and PRRT for Large GI Neuroendocrine Tumors.
Phase 1 · 2 location(s) · Emory University · NCT07150546

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.